Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A McKeating

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Clinics in Liver Disease|July 16, 2008
Hepatitis C virus entry and neutralizationZania Stamataki, Joe Grove, Peter Balfe, et al.
The Journal of General Virology|August 16, 2023
Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophagesMirjam Schilling, Alun Vaughan-Jackson, William James, et al.
Journal of Virology|June 15, 2004
Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteinsMike Flint, Carine Logvinoff, Charles M Rice, et al.
Plos One|October 13, 2011
Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivityZania Stamataki, Samantha Tilakaratne, David H Adams, et al.
Viruses|October 29, 2020
Oxygen Sensing and Viral Replication: Implications for Tropism and PathogenesisPeter Jianrui Liu, Peter Balfe, Jane A McKeating, et al.
Journal of Virology|February 14, 2003
Efficient replication of hepatitis C virus genotype 1a RNAs in cell cultureKeril J Blight, Jane A McKeating, Joseph Marcotrigiano, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 2017
Interplay between circadian clock and viral infectionXiaodong Zhuang, Srinivasa Bhargav Rambhatla, Alvina G Lai, et al.
Reviews in Medical Virology|March 7, 2012
Hepatitis C virus entry: beyond receptorsLuke W Meredith, Garrick K Wilson, Nicola F Fletcher, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
Type I interferon rapidly restricts infectious hepatitis C virus particle genesisLuke W Meredith, Michelle J Farquhar, Alexander W Tarr, et al.
Virology|March 1, 2025
Assessing the virological response to direct-acting antiviral therapies in the HBV cure programmeJames Lok, James M Harris, Ivana Carey, et al.
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Clinics in Liver Disease|July 16, 2008
Hepatitis C virus entry and neutralizationZania Stamataki, Joe Grove, Peter Balfe, et al.
The Journal of General Virology|August 16, 2023
Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophagesMirjam Schilling, Alun Vaughan-Jackson, William James, et al.
Journal of Virology|June 15, 2004
Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteinsMike Flint, Carine Logvinoff, Charles M Rice, et al.
Plos One|October 13, 2011
Rituximab treatment in hepatitis C infection: an in vitro model to study the impact of B cell depletion on virus infectivityZania Stamataki, Samantha Tilakaratne, David H Adams, et al.
Viruses|October 29, 2020
Oxygen Sensing and Viral Replication: Implications for Tropism and PathogenesisPeter Jianrui Liu, Peter Balfe, Jane A McKeating, et al.
Journal of Virology|February 14, 2003
Efficient replication of hepatitis C virus genotype 1a RNAs in cell cultureKeril J Blight, Jane A McKeating, Joseph Marcotrigiano, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 1, 2017
Interplay between circadian clock and viral infectionXiaodong Zhuang, Srinivasa Bhargav Rambhatla, Alvina G Lai, et al.
Reviews in Medical Virology|March 7, 2012
Hepatitis C virus entry: beyond receptorsLuke W Meredith, Garrick K Wilson, Nicola F Fletcher, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
Type I interferon rapidly restricts infectious hepatitis C virus particle genesisLuke W Meredith, Michelle J Farquhar, Alexander W Tarr, et al.
Virology|March 1, 2025
Assessing the virological response to direct-acting antiviral therapies in the HBV cure programmeJames Lok, James M Harris, Ivana Carey, et al.
Pageof 17